Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-06-11 to 2025-06-12
Current total value of award: $307.56
Description: 4568831043!XIFAXAN 200 MG TABLET 30S